The impact of rural residency on the expression and outcome of systemic lupus erythematosus: Data from a multiethnic Latin American cohort

Lupus

Volumn 21, Issue 13, 2012, Pages 1397-1404

  Pons Estel, G J ^a,b   Saurit, V ^c   Alarcon G S ^b   Hachuel, L ^d   Boggio, G ^d   Wojdyla, D ^d   Alfaro Lozano, J L ^e   De La Torre, I García ^f   Massardo, L ^g   Esteva Spinetti, M H ^h   Guibert Toledano, M ⁱ   Gómez, L A Ramirez ^j   Costallat, L T Lavras ^k   Del Pozo, M J Sauza ^l   Silveira, L H ^m   Cavalcanti, F ⁿ   Pons Estel, B A ^o  

^a Hospital Clinic   (Spain)

^b University of Alabama at Birmingham   (United States)

^c HOSPITAL PRIVADO   (Argentina)

^d UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

^e HOSPITAL NACIONAL GUILLERMO ALMENARA IRIGOYEN   (Peru)

^f HOSPITAL GENERAL DE OCCIDENTE   (Mexico)

^g PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^h Hospital Central de San Cristóbal   (Venezuela)

ⁱ Centro de Investigaciones Médico Quirúrgicas   (Cuba)

^j UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^k UNIVERSITY OF CAMPINAS   (Brazil)

^l Instituto Mexicano de Seguro Social   (Mexico)

^m INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

ⁿ Federal University of Pernambuco   (Brazil)

^o Hospital Provincial de Rosario ^*  (Argentina)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; METHOTREXATE;

ADULT; AFRICAN AMERICAN; ARTICLE; CAUCASIAN; DEMOGRAPHY; DISEASE ACTIVITY; EDUCATIONAL STATUS; FEMALE; HEMODIALYSIS; HUMAN; HYPERTENSION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; RURAL RESIDENCY; SOCIAL STATUS; SYSTEMIC LUPUS ERYTHEMATOSUS; URBAN AREA;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE FACTORS; AMERICAN NATIVE CONTINENTAL ANCESTRY GROUP; CHI-SQUARE DISTRIBUTION; COMORBIDITY; CONTINENTAL POPULATION GROUPS; CYCLOPHOSPHAMIDE; DISEASE PROGRESSION; EDUCATIONAL STATUS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH SERVICES ACCESSIBILITY; HEALTHCARE DISPARITIES; HUMANS; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; LATIN AMERICA; LOGISTIC MODELS; LONGITUDINAL STUDIES; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MEDICALLY UNINSURED; METHOTREXATE; MULTIVARIATE ANALYSIS; ODDS RATIO; PROGNOSIS; RENAL DIALYSIS; RESIDENCE CHARACTERISTICS; RISK FACTORS; RURAL HEALTH; SOCIOECONOMIC FACTORS; TIME FACTORS; URBAN HEALTH; YOUNG ADULT;

EID: 84867804302     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203312458465     Document Type: Article

References (30)

1. Escalante A, del Rincon I. Epidemiology and impact of rheumatic disorders in the United States Hispanic population. Curr Opin Rheumatol. 2001 ; 13: 104-110
2. Hopkinson N. Epidemiology of systemic lupus erythematosus. Ann Rheum Dis. 1992 ; 51: 1292-1294
3. Manzi S. Epidemiology of systemic lupus erythematosus. Am J Manag Care. 2001 ; 7: S474 - S479
4. Michet CJ Jr., McKenna CH, Elveback LR, et al. Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc. 1985 ; 60: 105-113
5. Naleway AL, Davis ME, Greenlee RT, et al. Epidemiology of systemic lupus erythematosus in rural Wisconsin. Lupus. 2005 ; 14: 862-866
6. Uramoto KM, Michet CJ Jr., Thumboo J, et al. Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis Rheum. 1999 ; 42: 46-50
7. Fessel WJ. Systemic lupus erythematosus in the community. Incidence, prevalence, outcome, and first symptoms; the high prevalence in black women. Arch Intern Med. 1974 ; 134: 1027-1035
8. Siegel M, Holley HL, Lee SL. Epidemiologic studies on systemic lupus erythematosus. Comparative data for New York City and Jefferson County, Alabama, 1956-1965. Arthritis Rheum. 1970 ; 13: 802-811
9. Ward MM. Hospital experience and expected mortality in patients with systemic lupus erythematosus: a hospital level analysis. J Rheumatol. 2000 ; 27: 2146-2151
10. Ward MM. Access to care and the incidence of end-stage renal disease due to diabetes. Diabetes Care. 2009 ; 32: 1032-1036
11. Yazdany J, Gillis JZ, Trupin L, et al. Association of socioeconomic and demographic factors with utilization of rheumatology subspecialty care in systemic lupus erythematosus. Arthritis Rheum. 2007 ; 57: 593-600
12. Pons-Estel BA, Catoggio LJ, Cardiel MH, et al. The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among " Hispanics". Medicine (Baltimore). 2004 ; 83: 1-17
13. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 ; 25: 1271-1277
14. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997 ; 40: 1725-1725
15. Graffar M. Une methode de classification sociale d'echantillons de population. Courrier. 1956 ; VI: 445-459
16. Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992 ; 35: 630-640
17. Gladman D, Ginzler E, Goldsmith C, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum. 1996 ; 39: 363-369
18. Alarcon GS, McGwin G, Bartolucci AA, et al. Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual. Arthritis Rheum. 2001 ; 44: 2797-2806
19. Petri M, Perez-Gutthann S, Longenecker JC, et al. Morbidity of systemic lupus erythematosus: role of race and socioeconomic status. Am J Med. 1991 ; 91: 345-353
20. Ward MM, Pyun E, Studenski S. Long-term survival in systemic lupus erythematosus. Patient characteristics associated with poorer outcomes. Arthritis Rheum. 1995 ; 38: 274-283
21. Ward MM. Access to care and the incidence of endstage renal disease due to systemic lupus erythematosus. J Rheumatol. 2010 ; 37: 1158-1163
22. Cooper GS, Wither J, Bernatsky S, et al. Occupational and environmental exposures and risk of systemic lupus erythematosus: silica, sunlight, solvents. Rheumatology (Oxford). 2010 ; 49: 2172-2180
23. Zandman-Goddard G, Solomon M, Rosman Z, et al. Environment and lupus-related diseases. Lupus. 2012 ; 21: 241-250
24. Parks CG, Cooper GS. Occupational exposures and risk of systemic lupus erythematosus: a review of the evidence and exposure assessment methods in population- and clinic-based studies. Lupus. 2006 ; 15: 728-736
25. Bernatsky S, Fournier M, Pineau CA, et al. Associations between ambient fine particulate levels and disease activity in patients with systemic lupus erythematosus (SLE). Environ Health Perspect. 2011 ; 119: 45-49
26. Costenbader KH, Kim DJ, Peerzada J, et al. Cigarette smoking and the risk of systemic lupus erythematosus: a meta-analysis. Arthritis Rheum. 2004 ; 50: 849-857
27. McClain MT, Heinlen LD, Dennis GJ, et al. Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nat Med. 2005 ; 11: 85-89
28. Costenbader KH, Gay S, Alarcón-Riquelme ME, et al. Genes, epigenetic regulation and environmental factors: which is the most relevant in developing autoimmune diseases?. Autoimmun Rev. 2012 ; 11: 604-609
29. Zandman-Goddard G, Berkun Y, Barzilai O, et al. Neuropsychiatric lupus and infectious triggers. Lupus. 2008 ; 17: 380-384
30. Ward MM. Avoidable hospitalizations in patients with systemic lupus erythematosus. Arthritis Rheum. 2008 ; 59: 162-168